These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 17169338)

  • 1. Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.
    Ukairo OT; Ramanujapuram S; Surratt CK
    Brain Res; 2007 Feb; 1131(1):68-76. PubMed ID: 17169338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate.
    Calipari ES; Ferris MJ; Siciliano CA; Jones SR
    ACS Chem Neurosci; 2015 Jan; 6(1):155-62. PubMed ID: 25474655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells.
    Chen N; Reith ME
    J Neurochem; 2007 Apr; 101(2):377-88. PubMed ID: 17250655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
    Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
    J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
    Chen R; Han DD; Gu HH
    J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
    Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
    Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter.
    Reith ME; Berfield JL; Wang LC; Ferrer JV; Javitch JA
    J Biol Chem; 2001 Aug; 276(31):29012-8. PubMed ID: 11395483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
    Mortensen OV; Amara SG
    J Neurochem; 2006 Sep; 98(5):1531-40. PubMed ID: 16923164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of methylphenidate and benztropine with the dopamine transporter is different than other substrates and ligands.
    Dar DE; Mayo C; Uhl GR
    Biochem Pharmacol; 2005 Aug; 70(3):461-9. PubMed ID: 15950948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.
    Saunders C; Ferrer JV; Shi L; Chen J; Merrill G; Lamb ME; Leeb-Lundberg LM; Carvelli L; Javitch JA; Galli A
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6850-5. PubMed ID: 10823899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.
    Ferris MJ; Calipari ES; Mateo Y; Melchior JR; Roberts DC; Jones SR
    Neuropsychopharmacology; 2012 Jun; 37(7):1708-16. PubMed ID: 22395730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties.
    Schmitt KC; Zhen J; Kharkar P; Mishra M; Chen N; Dutta AK; Reith ME
    J Neurochem; 2008 Nov; 107(4):928-40. PubMed ID: 18786172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.
    Freyberg Z; Sonders MS; Aguilar JI; Hiranita T; Karam CS; Flores J; Pizzo AB; Zhang Y; Farino ZJ; Chen A; Martin CA; Kopajtic TA; Fei H; Hu G; Lin YY; Mosharov EV; McCabe BD; Freyberg R; Wimalasena K; Hsin LW; Sames D; Krantz DE; Katz JL; Sulzer D; Javitch JA
    Nat Commun; 2016 Feb; 7():10652. PubMed ID: 26879809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the dopamine transporter by phosphorylation.
    Foster JD; Cervinski MA; Gorentla BK; Vaughan RA
    Handb Exp Pharmacol; 2006; (175):197-214. PubMed ID: 16722237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine transporter: a vigilant border control for psychostimulant action.
    Williams JM; Galli A
    Handb Exp Pharmacol; 2006; (175):215-32. PubMed ID: 16722238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of gamma-synuclein in cocaine-induced behaviour in rats.
    Boyer F; Dreyer JL
    Eur J Neurosci; 2008 Jun; 27(11):2938-51. PubMed ID: 18588534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
    Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
    Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner.
    Pifl C; Wolf A; Rebernik P; Reither H; Berger ML
    Neuropharmacology; 2009 Feb; 56(2):531-40. PubMed ID: 19000913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes.
    Tidjane Corera A; Do-Régo JC; Costentin J; Bonnet JJ
    Neurosci Res; 2001 Mar; 39(3):319-25. PubMed ID: 11248372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.